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ABSTRACT
Objective The Glasgow- Blatchford Bleeding Score 
(GBS) was designed to identify patients with upper 
gastrointestinal bleeding (UGIB) who do not require 
hospitalisation. It may also help stratify patients unlikely to 
benefit from intensive care.
Design We reviewed patients assigned a GBS in the 
emergency room (ER) via a semiautomated calculator. 
Patients with a score ≤7 (low risk) were directed to an 
unmonitored bed (UMB), while those with a score of ≥8 
(high risk) were considered for MB placement. Conformity 
with guidelines and subsequent transfers to MB were 
reviewed, along with transfusion requirement, rebleeding, 
length of stay, need for intervention and death.
Results Over 34 months, 1037 patients received a GBS 
in the ER. 745 had an UGIB. 235 (32%) of these patients 
had a GBS ≤7. 29 (12%) low- risk patients were admitted 
to MBs. Four low- risk patients admitted to UMB required 
transfer to MB within the first 48 hours. Low- risk patients 
admitted to UMBs were no more likely to die, rebleed, 
need transfusion or require more endoscopic, radiographic 
or surgical procedures than those admitted to MBs. No 
low- risk patient died from GIB. Patients with GBS ≥8 
were more likely to rebleed, require transfusion and 
interventions to control bleeding but not to die.
Conclusion A semiautomated GBS calculator can be 
incorporated into an ER workflow. Patients with a GBS ≤7 
are unlikely to need MB care for UGIB. Further studies are 
warranted to determine an ideal scoring system for MB 
admission.
BACKGROUND
Patients with upper gastrointestinal bleeding 
(UGIB) often present dramatically with 
haematemesis or melena, hypotension and 
even syncope. Because the aetiology of 
bleeding is usually unknown and behaviour 
uncertain at the time of admission, even 
stable patients may be admitted to a high 
acuity intensive care unit (ICU) with contin-
uous patient monitoring and close nursing 
care. However, most patients with GI bleeding 
do not benefit from ICU care.1 Unneces-
sary ICU admissions increase costs and may 
impede access to other critically ill patients. 
A recent analysis revealed broad variability 
in ICU admission for UGIB among different 
hospitals with no difference in outcomes.2
The Glasgow- Blatchford Bleeding Score 
(GBS) (online supplemental appendix A) was 
designed to identify low- risk patients (score 
<1) who could be safely discharged from the 
emergency room (ER) after presenting with 
UGIB.3 More recent studies have shown that 
the GBS can predict a need for endoscopic 
intervention,4 blood transfusion5 and urgent 
endoscopy.6
The 2010 Toronto consensus guidelines 
for UGIB advocated risk stratification in the 
ER using the GBS or another validated tool.1 
In 2012, the Swedish Medical Center began 
including a GBS for all patients seen in the 
ER with suspected UGIB. A ‘smart phrase’ 
was created in the hospital electronic health 
record (EHR) (EPIC) to auto- populate rele-
vant fields of the GBS in hope of improving 
Summary box
What is already know about this subject?
 ► The Glasgow- Blatchford Bleeding Score (GBS) was 
designed to identify low- risk upper gastrointestinal 
bleeding (UGIB) patients who could be safely dis-
charged from the emergency room. Subsequent 
studies have shown that the GBS can help predict 
rebleeding and need for transfusion.
What are the new findings?
 ► This study shows that the GBS can be used to iden-
tify patients who do not need intensive monitoring 
after admission.
How might it impact on clinical practice in the 
foreseeable future?
 ► Better understanding and use of predictive tools 
could help reduce costs and resource allocation as-
sociated with treating UGIB.
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its use. In addition to identifying very low- risk patients, 
the score was also used to stratify lower- risk patients to 
help reduce unnecessary ICU admissions. Analysis at 6 
months revealed an 18% reduction in hospital expenses 
for UGIB patients, about US$2000 per admission, with 
no identifiable adverse outcomes, due in large part to 
shorter lengths of stay and a decrease in admission to 
ICU.7 The current study was undertaken to assess the 
utility of the GBS to direct bed placement for patients 
with UGIB.
METHODS: 
We reviewed all patients over 18 years of age admitted 
with symptoms of GI bleeding who were assigned a 
GBS through Swedish Medical Center’s ER between 1 
January 2015 and 31 October 2017. ER physicians were 
asked to insert a GBS template within the body of their 
admission note in the EHR. The template pulls recent 
lab data and vital signs from the EHR to populate blood 
urea nitrogen, haemoglobin level, systolic blood pressure 
and pulse. Additional boxes address melena, syncope, 
heart and liver disease history and are manually entered. 
The EHR then calculates a score from 0 to 23 and places 
it in the note. The score is accompanied by verbiage 
suggesting admission to an unmonitored bed (UMB) for 
patients with a score of 1–7, a monitored, intermediate 
care (IMCU) bed for a score of 8–12 and ICU placement 
for a score of 13 or higher, but also notes that physicians 
may direct patients to a different unit based on clinical 
judgement, (online supplemental appendix B).
Because of major similarities between IMCU and ICU 
layout, equipment, staffing and other expenses, as well 
as frequent flexing of ward designations based on census 
and staffing, for analysis, admissions to both units were 
grouped and designated MBs. General medical/surgical 
ward and telemetry beds were considered UMBs, because 
of similar staffing levels and cost.
All patients were admitted to hospitalist or intensivist 
services with hospital- based GI consultation. Urgent 
endoscopy, within 24 hours of admission, was available 
for all patients regardless of unit.
Using discharge diagnoses and endoscopic findings, 
we identified patients who had or were likely to have had 
an UGIB from any source. Those with bleeds distal to 
the ligament of Treitze were analysed separately. Those 
with uncertain bleeding were excluded. We catego-
rised patients by their admitting GBS and determined 
whether the admitting team followed recommendations 
for bed assignment. For patients admitted outside of the 
recommendations, the physicians’ notes were used to 
determine the reason for bed placement and to review 
the subsequent hospital course. Patients transferred 
to a higher level of care within the first 48 hours were 
also reviewed. We collected data on in- hospital mortality, 
rebleeding, length of stay, transfusion requirement, 
need for endoscopy and radiographic and surgical inter-
ventions. We reviewed in- hospital deaths to determine 
if they resulted from GI bleeding and whether delay in 
any intervention may have contributed to mortality. We 
compared outcomes among groups who received bed 
assignments within and outside of guidelines. We also 
reviewed a separate cohort of patients during the same 
period to calculate the actual use of the GBS for patients 
with GIB symptoms.
The Fisher’s exact test was used for comparison of 
categorical data, and an independent t- test was used 
for continuous data. Analyses were performed by using 
GraphPad Prism statistical software, V.8 (GraphPad Soft-
ware, La Jolla, California, USA). A p<0.05 was considered 
as statistically significant.
RESULTS: 
Over 34 months, 1037 patients were admitted through 
the ER with a presumption of GIB and also received a 
GBS. Of these, 745 had evidence of an UGIB, 244 were 
determined to have had a lower gastrointestinal bleed 
(LGIB), 23 had evidence of a small bowel bleed and for 
25 no cause was identified. Among patients with UGIB, 
235 (32%) had a GBS≤7 and 510 (68%) scored 8 or 
higher. Twenty- nine (12%) patients in the low- risk group 
were admitted to an MB (28 IMCU, 1 ICU) despite guide-
lines, (table 1). Among patients with scores>7, 149 (29%) 
were admitted to UMBs while 287 went to IMCU and 74 
to ICU. Among those who went to ICU 58 had GBS≥12, 
representing 38% of that group. Low- risk patients were 
more likely to receive a protocol directed admission than 
high- risk patients (p=0.03).
Of the 745 patients suspected of having had an UGIB, 
607 had this confirmed by upper endoscopy during that 
admission. The remaining 138 individuals who did not 
undergo endoscopy all presented with symptoms of 
haematemesis, melena or profound anaemia and had a 
documented upper endoscopy within the past year for 
UGIB that revealed a likely source of recurrent bleeding, 
Table 1 Patients admitted with UGIB
GBS ≤7 ≥8 P value
No 235 510
Median age 66 71 0.02
Female 45% 50% 0.49
LOS (average in hours) 70 123 <0.01
Unit assignment by 
protocol
206 (88%) 361 (71%) 0.03
Underwent urgent 
endoscopy
150 (64%) 457 (90%) 0.01
Required transfusion 30 (13%) 360 (71%) <0.01
Experienced rebleed 12 (5%) 71 (14%) <0.01
Radiographic or surgical 
intervention
2 (1%) 19 (4%) 0.03
Death 5 (2%) 20 (4%) 0.27
GBS, Glasgow- Blatchford Bleeding Score; LOS, length of stay; 
UGIB, upper gastrointestinal bleeding.
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(erosive oesophagitis, alcoholic gastritis, etc). Average 
time to endoscopy was 19 hours from admission and 
access to endoscopy was not affected by unit placement. 
Patients who had previous endoscopy that suggested 
a likely source of current bleeding and were not felt to 
need endoscopic therapy did not necessarily undergo 
repeat endoscopy.
High- risk patients tended to be older, had longer admis-
sions, were more likely to undergo urgent endoscopy, 
transfusion and experience rebleeding as well as require 
a non- endoscopic intervention to control bleeding than 
low- risk patients, but were no more likely to die during 
admission.
Because the GBS was not universally applied to all 
patients presenting with UGIB symptoms, we sought to 
understand rate of use of the GBS score among ER physi-
cians. A separate group of all patients who presented to 
the ER during the same period with the very specific Inter-
national Classification of Diseases, tenth revision, clinical 
modification (ICD-10- CM) codes K92.0 (haematemesis) 
or K92.1 (melena) were reviewed, as this group repre-
sented patients who clearly would have qualified for 
including a GBS. Of 644 patients, 405 (63%) received a 
GBS in the ER while 239 (37%) were not scored. Among 
47 ER physicians, GBS use ranged from 0% to 92% with 
the top quartile averaging 81% and the lowest quartile 
42%. The 405 patients with scores are included in the 
study cohort. The remaining study patients received 
other ICD-10- CM codes at admission.
Within the low- risk group, 29 patients were admitted 
directly to an MB from the ER. Admission notes suggest 
concern about rapid deterioration by the ER, hospitalist 
or GI physician due to a history of cirrhosis and possible 
oesophageal varices in 3 (10%) patients, other history of 
alcohol abuse or withdrawal in 6 (21%), advanced age or 
medical fragility in 7 (24%), very low haematocrit in 4 
(14%), new or active bleeding in the ER in 4 (14%) and 
active infection or sepsis in 2 (7%). No clear reason for 
MB assignment could be identified for five patients. The 
presence of liver disease, beyond its effect on the GBS, 
did not appear to direct patients to an MB.
Low- risk patients who were admitted to UMBs had 
a lower average GBS than those admitted to MBs. In 
order to better compare these groups, we excluded four 
patients admitted to MBs for non- bleeding symptoms 
such as mental status changes or respiratory symptoms 
who had a GBS <5 and compared the remaining 25 to a 
score- matched group of patients (from 5 to 7) admitted 
to UMBs, (table 2). MB patients were similar to UMB 
patients in regard to age and gender. Within this cohort, 
there was no difference in transfusions, rebleeding, 
frequency of endoscopy or death. Patients admitted to 
MBs stayed almost a day longer than those in UMBs, 
but this did not reach significance. None of the low- risk 
patients admitted to MBs required emergent intubation, 
cardioversion or vasopressors.
Four (2%) low- risk (GBS ≤7) patients required MB 
transfer within the first 48 hours (table 3). Three transfers 
were made out of caution based on new findings and were 
discharged home within 2 days. One patient ultimately 
died due to mesenteric ischaemia despite intubation and 
aggressive support. None of these patients experienced 
recurrent bleeding.
He was one of 5 (2%) low- risk patients who died during 
an admission for UGIB (table 4). All of these patients 
were elderly and/or had significant underlying illness. 
Three were had ‘do not resuscitate’ orders or were under 
palliative care plans at admission. None of these deaths 
appeared to have directly resulted from GI bleeding.
High- risk patients (GBS ≥8) admitted to MBs did 
not differ significantly from those admitted to UMB in 
terms of age or gender but did a tend to have a higher 
average GBS (11.8 vs 10.3 p<0.01). Patients admitted to 
MBs tended to have a longer length of stay, require blood 
transfusions and rebleed. Despite this, death rates were 
similar (table 5).
Ten (6.7%) high- risk patients initially admitted to an 
UMB required transfer to an MB (table 6). Two (1.3%) 
eventually died. An 80- year- old man with a GBS of 10 died 
of aspiration and sepsis. A review suggested that closer 
monitoring and care from the outset may have prevented 
this. A 50- year- old woman with a GBS of 9 died of enceph-
alopathy and liver failure despite timely transfer to MB 
and intubation. The most common reason for transfer 
was respiratory failure (50%).
DISCUSSION
GI bleeding represents the most common cause for 
admission to hospital GI services in the USA, accounting 
for up to 500 000 admissions per year8 with 1.9% all- cause 
mortality.9 Many UGIB patients present with some degree 
of haemodynamic instability. Uncertainty about the 
source of bleeding combined with the spectre of rapid 
deterioration can lead to ICU admission. Most of these 
patients however never need specialised ICU services 







Median age 68 67 0.91
Female 40% 42% 0.98
Average GBS 6.2 6.3 0.45
LOS (av in hours) 71 91 0.14
Underwent urgent 
endoscopy
76 (70%) 17 (68%) 0.98
Required transfusion 17 (16%) 6 (24%) 0.38
Experienced rebleed 8 (7%) 3 (12%) 0.43
Radiographic or 
surgical intervention
1 (1%) 1 (4%) 0.35
Death 1 (1%) 1 (4%) 0.35
GBS, Glasgow- Blatchford Bleeding Score; LOS, length of stay.
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such as intubation, central monitoring or urgent cardio-
version. ICU and other MBs demand significantly more 
resources than UMBs and may be a scarce commodity in 
some hospitals. Admission to an ICU may also lead to more 
invasive procedures and longer length of stay, without 
necessarily producing better outcomes.2 ICU admissions 
for UGIB vary widely in the USA. A recent study of 94 
acute care, non- federal hospitals showed that ICU admis-
sion rates for UGIB ranged from 11.5% to 51.2%, without 
any demonstrable difference in mortality.2 Another study 
estimated that up to 40% of ICU admissions for UGIB are 
unnecessary.10
In our own institution, the expense of (not charge 
for) an ICU bed is about 2.5 times that of an UMB. A 
step- down or IMCU bed is almost as expensive at about 
twice the price of an UMB. This is driven largely by 
higher staffing costs for both units. The level of care in 
the Swedish IMCU resembles ICU care in many hospitals 
with large, glass fronted individual rooms with central, 
remote monitoring and patient to nurse ratios that do 
not exceed 3:1. In fact, IMCU and ICU rooms are iden-
tical and differ in designation only when staffing levels 
change. In this study, because of the similar costs and level 
of care provide in ICU and IMCU and frequent shifting of 
patients between the two units for non- medical reasons, 
we chose to combine admissions to these two units and 
compare them to admissions to UMBs, specifically for 
lower- risk patients. Most patients in this study who were 
admitted to MBs were actually admitted to IMCU rather 
than ICU (315 vs 75 or 81%). We felt that because of the 
broad variation in design and staffing of ICUs and other 
MBs among different institutions, a clearer distinction in 
cost and care could be drawn between monitored and 
UMBs rather than among multiple different levels of 
monitoring and care. The goal was not so much to deter-
mine whether the GBS identifies an ideal level of care 
for each person, but rather to see if a score exists below 
which monitored care may not be necessary.
The decision to direct patients with a GBS ≤7 to an UMB 
was not arbitrary. Preventing morbidity and mortality 
that might result from haemodynamic compromise 
remains the primary goal of admitting UGIB patients 
to an MB. A patient in an MB can receive rapid trans-
fusion and fluid replacement, vasopressor support and 
in extreme cases, undergo intubation and cardioversion. 
In addition, close nursing support and constant haemo-
dynamic monitoring can theoretically identify sequalae 
of bleeding more rapidly. But studies suggest that rapid 
blood loss is unlikely at GBS ≤7. Bryant et al11 reviewed 888 
patients with UGIB and found no patient who needed 
endoscopic or surgical intervention had an admission 
GBS below 8. Chatten et al12 reviewed 399 patients with 
UGIB and found that over 92% of patients with a GBS 
≤8 did not need endoscopic therapy. Robertson et al13 in 
a study of 424 patients with UGIB suggested that a GBS 
of 9 for requiring ICU admission (88% sensitive and 
44% specific) and a score of 10 was 76% sensitive and 
86% specific for needing transfusion. A cut- off of 7 was 
felt to exclude the vast majority of patients with active, 
haemodynamically significant bleeding requiring aggres-
sive support. Ready access to endoscopic diagnosis and 
intervention for patients in UMBs as well as ability to 
rapidly transfer deteriorating or unstable patients to an 
MB provided additional reassurance. Internal review of 
Table 3 Low- risk (GBS ≤7) patients who were transferred to MB within first 48 hours
Age Gender GBS score Reason for transfer Outcome
68 F 4 New atrial fibrillation Discharge home
30 F 7 Varices banded at endoscopy Discharge home
77 F 3 Oesophageal ulcer at endoscopy Discharge home
64 M 4 Lactic acidosis, severe vascular disease Death
F, female; GBS, Glasgow- Blatchford Bleeding Score; M, male; MB, monitored bed.
Table 4 Low- risk (GBS ≤7) patients who died during admission for UGIB
Age Gender GBS score Initial admission
Length of 
hospitalisation 
(in days) Cause of death Code status
64 M 4 UMB 2 Mesenteric ischaemia Full Code
88 M 4 UMB 7 Aspiration pneumonia DNR
88 M 6 UMB 3 Congestive heart failure DNR
66 F 7 MB 7 Cirrhosis, COPD, 
respiratory failure
Full Code
86 M 7 MB 2 Oesophageal cancer, 
aspiration pneumonia
DNR
COPD, chronic obstructive pulmonary disease; DNR, do not resuscitate; F, female; GBS, Glasgow- Blatchford Bleeding Score; M, male; MB, 
monitored bed; UGIB, upper gastrointestinal bleeding; UMB, unmonitored bed.
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6 months of patient with GBS ≤7 also suggested safety at 
this level.
This study demonstrates that the GBS can identify a 
threshold below which the likelihood of sudden deterio-
ration from bleeding is very low. In the study population, 
low- risk patients accounted for about a third of those 
admitted with UGIB. Despite guidelines, 12% of low- risk 
patients were admitted to MBs. Caution appears to have 
driven most of these decisions. Despite a higher level of 
care, the treatments and outcomes for these patients did 
not differ significantly from those admitted to UMBs. 
Two patients required intubation yet both died. It is 
impossible to tell if any of the surviving patients bene-
fited from the higher level of nursing care or haemody-
namic monitoring. While five low- risk patients ultimately 
died and four others were transferred to MBs, none was 
the direct result of bleeding. It is not surprising and ulti-
mately appropriate that some very elderly patients or 
those with terminal conditions were not placed in MBs 
as aggressive interventions would likely not have changed 
outcomes. Transfers to MBs that did occur were timely 
and no adverse outcomes appeared to have resulted from 
primary UMB placement.
The GBS alone proved less effective for identifying 
those who truly need an MB. Evidence- based guidelines 
have suggested that haemodynamically unstable patients 
and those with GBS ≥12 may benefit from endoscopy as 
early as 12 hours after admission.14–17 Although formal 
guidelines for ICU care for this group are lacking, it 
might be assumed that patients unstable enough to 
benefit from very early endoscopy would also benefit 
from the highest level of care. However, a small subgroup 
of 16 patients with a GBS ≥13 did as well in UMBs as those 
in MBs. These patients tended to have higher scores due 
to renal failure or severe anaemia but were otherwise 
haemodynamically stable.
Roughly half of all UGIB patients had a GBS between 
8 and 12. One- third of these patients did well in UMBs 
and likely others would have as well. However, 10 (8%) 
patients in this group, initially felt by the ER physician 
to be low risk, required transfer to an MB. Four had 
respiratory compromise or aspiration while two devel-
oped mental status changes associated with alcohol with-
drawal or cirrhosis. Two of these patients ultimately died 
but neither from ongoing bleeding. Seven other deaths 
occurred among patients with scores between 8 and 10, 
despite primary admission to an MB. This is consistent 
with the findings of other studies that UGIB patients at 
highest risk of mortality suffer from comorbidities such as 
alcohol withdrawal, cirrhosis, and cancer6 and rarely die 
directly from bleeding.18 The large number of high- risk 
patients (32%) who were successfully treated in UMBs 
suggests that other factors not captured by the GBS such 
as age, alcohol withdrawal or respiratory compromise 
should be considered when making bed selection and 







Median age 75 71 0.14
Female 52% 49% 0.80
Average GBS 10.3 11.8 0.01





125 (84%) 329 (91%) 0.57
Required 
transfusion
77 (52%) 279 (77%) 0.01
Experienced 
rebleed




3 (2%) 17 (5%) 0.22
Death 5 (3%) 15 (4%) 0.78
GBS, Glasgow- Blatchford Bleeding Score; LOS, length of 
stay.
Table 6 High- risk (GBS ≥8)) patients initially admitted to an UMB who were transferred to MB within 48 hours
Age Gender GBS score Reason for transfer Outcome
83 F 9 Respiratory compromise Discharge home
74 F 9 Recurrent bleeding Discharge home
50 F 9 Liver and respiratory failure Death
92 M 10 Respiratory compromise, CHF Discharge home
78 F 10 Persistent anaemia and arrhythmia Discharge home
48 M 10 Alcohol withdrawal, encephalopathy Discharge home
56 M 10 Alcohol withdrawal, aspiration Discharge home
80 M 10 Aspiration pneumonia Death
43 M 10 Large duodenal ulcer at endoscopy Discharge home
75 F 12 Recurrent bleeding Discharge home
CHF, congestive heart failure; F, female; GBS, Glasgow- Blatchford Bleeding Score; M, male; MB, monitored bed; UMB, unmonitored bed.
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that the absence of these conditions may enable safe 
UMB placement for UGIB patients with a GBS ≥8. What 
the safe GBS upper limit might be and what other factors 
may be necessary predict safe UMB placement are not 
identified in this study.
While risk assessment tools aid ICU decision making 
for other conditions,19–21 none of the half dozen 
common risk tools for GI bleeding are widely used for 
this purpose.12 22 23 The Rockall Score, Baylor Bleeding 
Score and Cedars- Sinai Predictive Index rely in part on 
endoscopic elements that are generally not available to 
the ER physician.24 The GBS, the AIMS65 score as well as 
the clinical Rockall score rely only on vital signs, labs and 
historical elements that are almost always available in the 
first hours of evaluation. The GBS has been shown to help 
predict need for urgent endoscopy13 and blood transfu-
sion,20 two factors that might suggest a need for higher 
level of care,5 but has not been previously reported as 
a tool for bed assignment. The GBS remains the most 
widely studied risk stratification tool for UGIB and 
appears to be more sensitive than either of the Rockall 
scores.4 20
The AIMS65 score, which incorporates age and 
albumin level but not subjective or historical elements 
like syncope and liver disease, appears to be more accu-
rate for predicting mortality and length of stay,25 but 
may be less accurate than the GBS for predicting recur-
rent bleeding or transfusion requirement.26 27 However, 
predicting death in patients with advanced age and 
multiple comorbidities may not clearly translate into 
better outcomes with early MB admission. The AIMS65 
score is easier to memorise and calculate than the GBS, 
but this advantage fades when the EHR automates it.
Despite recommendations to incorporate them into 
decision making in the ER, risk scores are not used 
widely.1 Many physicians feel that risk scores are not 
particularly useful or don’t work any better than an ER 
physician’s judgement.28 29 It may also be that even simple 
scores require too much effort to remember and apply 
than most busy physicians are willing to invest.
This study shows that by leveraging the data grabbing 
functions of an EHR, the GBS can be easily incorporated 
into the ER assessment. But even this feature did not lead 
to rapid adoption. Only after months of intense educa-
tion did ER physicians begin to use the GBS calculator 
regularly, and even then, not consistently. However, once 
adopted, the GBS began to serve as an efficient short 
hand among ER physicians, hospitalists and gastroenter-
ologists, replacing a long list of vital signs and labs with a 
simple, widely understood number.
Because the source of GI bleeding is often unclear at 
presentation, the ideal risk score would have utility for 
LGI bleeding as well. While several scores have been 
proposed to predict mortality and other outcomes 
for patients with LGI bleeding, studies have emerged 
showing that the GBS has reasonable accuracy for iden-
tifying low- risk patients with LGI bleeding.30 31 This 
study supports those findings and demonstrates that the 
GBS may effectively identify low- risk patients with LGI 
bleeding safe for UMBs. A total of 244 patients who were 
ultimately found to have had lower GI bleeding had a 
bleeding score calculated at admission. The GBS directed 
117 of 133 (88%) low- risk patients to UMBs. None of 
these patients suffered an adverse event or poor outcome 
as a result of their bed placement. Four low- risk patients 
were transferred to MBs within 48 hours. Three who were 
transferred out of caution due to cirrhosis, alcohol with-
drawal and ongoing bleeding were discharged within 
48 hours of transfer. One patient with a diverticular 
source continued to bleed despite angiography and ulti-
mately underwent haemicolectomy.
Any cost savings from using the GBS remains unknown. 
An earlier review at our institution of 166 UGIB patients 
revealed that using the GBS along with other elements 
aimed at improving physician communication decreased 
ICU admissions by 42%, LOS by 14% and hospital 
expense by 18%.7 Chang and Shapiro estimated that if 
ICU care for UGI bleeding patients in higher utilisation 
hospitals were reduced to levels of lower utilisation hospi-
tals, total costs would drop by about 6.5%.2
Several elements limit this study. First, the GBS for 
bed placement is limited because it does not take into 
account comorbidities and risk factors beyond GI 
bleeding. Many low- risk patients were admitted to MBs 
based on ER physicians’ concerns about other condi-
tions and less than a third were redirected based on a 
concern about bleeding. Two who died succumbed to 
respiratory complications without rebleeding and none 
in this group needed aggressive haemodynamic inter-
ventions to control bleeding. But there is no way of 
knowing whether this small group would have done as 
well in UMBs. However, this does demonstrate the real 
world applicability of these guidelines; physicians had no 
problem admitting outside of guidelines when a patient 
appeared at higher risk.
Just under a fifth of patients with signs of UGI bleeding 
did not undergo endoscopy during the index admission. 
Although all had a diagnostic endoscopy within the last 
year, the true cause of these bleeds was not documented. 
The number and types of endoscopic interventions are 
also not captured in this data, nor are the final diagnoses, 
incidence of liver disease and bleeding source for all 
patients. While more granular data may help us better 
understand which patients are ultimately more likely to 
rebleed or do poorly, the source of the bleed is almost 
always obscure at the time of admission and the pres-
ence of cirrhosis may also be unknown. The ideal risk 
score should aid in placement without having to know 
the source of bleeding if no diagnostic or interventional 
endoscopy is necessary. In this study, two individuals in 
the lower- risk group were admitted to MBs because of a 
concern for varices and one other who was found to have 
non- bleeding varices after index endoscopy was trans-
ferred to the ICU for observation. Others may have had 
cirrhosis that was not initially identified but did not lead 
to deterioration or require MB transfer.
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During the study period, up to 37% of patients with 
UGIB may have been missed because some ER physi-
cians did not use the automated system. However, it does 
not appear that any specific risk groups were excluded. 
This suggests that, although incomplete, the cohort was 
representative of patients who present with UGIB. The 
study also does not look at hospital readmissions or 
post hospital deaths, although an adverse effect from 
improper bed placement would likely become apparent 
during that admission and not after discharge. Some 
subgroup analyses involve small numbers of patients, 
limiting the ability to demonstrate differences.
The findings of this study may not be universally appli-
cable. Hospitals, their staffs and their skill sets differ. 
While patients with a score of 7 may consistently do well 
in an UMB at a facility where access to endoscopy is easy 
and ICU beds plentiful, the same may not be true for 
smaller hospitals with fewer ICU beds and inconsistent 
specialty coverage. Similarly, some facilities may not have 
ready access to a 24- hour endoscopy unit and depend 
on MBs for urgent endoscopy. Although it appears that 
a GBS ≤7 predicts a low risk of deterioration, a hospital’s 
unique profile and ability to manage these problems 
should determine cut- off levels for MB placement or 
transfer.
CONCLUSION
This study demonstrates that UGIB patients with a GBS≤7 
in the ER should be admitted to UMBs in the absence of 
other major comorbidities or signs of rapid deterioration. 
The ease with which EHRs can incorporate the score into 
ER workflows suggests that greater use and acceptance 
of the tool could reduce unnecessary MB admissions. In 
its current form, the GBS lacks the precision to serve as 
the sole determinant of bed placement for higher- risk 
patients.
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